Neoplasms, Hematologic Unknown Status Phase 4 Trials for Filgrastim (DB00099)

Also known as: Hematological Neoplasm / Hematological Neoplasms / Hematologic Neoplasm / Hematologic Neoplasms / Haematological neoplasm / Malignant tumor of lymphoid hemopoietic and related tissue (disorder) / Haematological malignancy / Hematological malignancy / Hematologic neoplasm (disorder)

IndicationStatusPhase
DBCOND0056760 (Neoplasms, Hematologic)Unknown Status4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03844360Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic DiseaseTreatment